Evidence for presynaptic cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the guinea pig lung

European Journal of Pharmacology

Volumn 431, Issue 2, 2001, Pages 237-244

  Vizi, E Sylvester ^a   Katona, István ^a   Freund, Tamás F ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Bronchospasm; Cannabinoid CB1 receptor; Lung; Noradrenaline release

Indexed keywords

14ALPHA HYDROXY 7,8 METHYLENEDIOXYALLOBERBANE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; CANNABINOID 1 RECEPTOR; NEUROPEPTIDE Y; NORADRENALIN; PRAZOSIN; RIMONABANT; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; BREATHING MUSCLE; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; GUINEA PIG; IC 50; LUNG; MUSCLE INNERVATION; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOACTIVITY; SYMPATHETIC INNERVATION; ULTRASTRUCTURE;

ANIMALS; BERBERINE; BRONCHI; ELECTRIC STIMULATION; FEMALE; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; LUNG; MALE; NEUROPEPTIDE Y; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, PRESYNAPTIC; TRITIUM;

EID: 0035900609     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01413-3     Document Type: Article

References (44)

1. 9-Tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: A microdialysis study
2. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices
3. Cannabinoid receptor mediated inhibition of excitatory synaptic transmission in the rat hippocampal slice is developmentally regulated
4. Modulation of neurotransmission in airways
5. 1 receptor
6. Bidirectional control of airway responsiveness by endogenous cannabinoids
7. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus
8. Neuropeptide Y innervation of ACTH-immunoreactive neurons in the arcuate nucleus of rats: A correlated light and electron microscopic double immunolabeling study
9. Factors that determine acetylcholine responsiveness of guinea pig tracheal tubes
10. Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves
11. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN-55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A
12. 3H]noradrenaline from mouse cultured sympathetic neurons: Release-modulating heteroceptors
13. Prejunctional alpha2 adrenoceptors inhibit contraction of tracheal smooth muscle by inhibiting cholinergic neurotransmission
14. Cannabinoids inhibit hippocampal GABA(ergic) transmission and network oscillations
15. 2-agonist- and dexamethasone-treatment on relaxation and regulation of β-adrenoceptors in human bronchi and lung tissue
16. A synaptic transmission in the hippocampus
17. 1 receptors on peripheral sympathetic nerves
18. Ultrastructural study of guinea pig tracheal smooth muscle and its innervation
19. 1 receptors regulate GABA release from axon terminals of specific hippocampal interneurons
20. GABA(ergic) interneurons are the targets of cannabinoid actions in the human hippocampus
21. 1 receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures
22. 1 receptors in the rat and mouse
23. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons
24. Effect of cannabinoid receptor agonist WIN-55212-2 on sympathetic cardiovascular regulation
25. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip
26. 2 receptors
27. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens
28. 1 receptors in mouse vas deferens
29. The endocannabinoid system as a target for therapeutic drugs
30. SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor
31. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide
32. 1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus
33. 2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones
34. Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: Role in the modulation of acetylcholine release from parasympathetic nerves
35. 3H]noradrenaline by veratridine and ischema in spinal cord
36. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata
37. Regulation of noradrenaline release by presynaptic receptor systems
38. 2-adrenoceptor
39. 3H]noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and β-adrenoceptors in mouse tissues
40. 1 receptor can sequester G-proteins making them unavailable to couple to other receptors
41. Alpha-adrenoceptors, presynaptic modulation: Facts and hypothesis
42. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the CNS
43. Release and turnover of noradrenaline in isolated median eminence: Lack of negative feedback modulation
44. 2-adrenoceptors